Analyst Ratings for Halozyme Therapeutics (halo)

halo Rating Summary

halo Price Target Summary

* Over Last 12-Mos
  |   Expand Research on halo
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $13.10 (+43.2%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
7/11/2014 JPMorgan New Coverage Overweight
(N/A)
13.00
(N/A)
9.29 9.15 -1.51% Details
6/12/2014 UBS Upgrade Buy
(Neutral)
N/A
(N/A)
9.39 9.15 -2.56% Details
Like HALO Ratings? Also take a look at BAX, XON, BCRX, DYAX

HALO Ratings News